1. Home
  2. IVT vs PGEN Comparison

IVT vs PGEN Comparison

Compare IVT & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InvenTrust Properties Corp.

IVT

InvenTrust Properties Corp.

N/A

Current Price

$31.53

Market Cap

2.5B

Sector

Real Estate

ML Signal

N/A

Logo Precigen Inc.

PGEN

Precigen Inc.

N/A

Current Price

$4.52

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IVT
PGEN
Founded
2005
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.8B
IPO Year
2005
2013

Fundamental Metrics

Financial Performance
Metric
IVT
PGEN
Price
$31.53
$4.52
Analyst Decision
Buy
Buy
Analyst Count
9
4
Target Price
★ $34.38
$13.67
AVG Volume (30 Days)
554.8K
★ 7.3M
Earning Date
10-27-2026
11-04-2026
Dividend Yield
★ 3.17%
N/A
EPS Growth
★ 647.37
N/A
EPS
★ 0.33
0.12
Revenue
★ $299,169,000.00
$230,981,000.00
Revenue This Year
$13.44
$2,380.31
Revenue Next Year
$5.81
$84.01
P/E Ratio
$95.42
★ $37.79
Revenue Growth
★ 9.20
N/A
52 Week Low
$27.44
$3.04
52 Week High
$37.22
$8.98

Technical Indicators

Market Signals
Indicator
IVT
PGEN
Relative Strength Index (RSI) 55.86 34.68
Support Level $30.49 $3.65
Resistance Level $31.71 $5.75
Average True Range (ATR) 0.67 0.47
MACD 0.10 -0.08
Stochastic Oscillator 63.64 19.48

Price Performance

Historical Comparison
IVT
PGEN

About IVT InvenTrust Properties Corp.

InvenTrust Properties Corp is the United States of America based company qualified as a REIT (Real Estate Investment Trust). It is focused on owning, leasing, redeveloping, acquiring and managing a multi-tenant retail platform. The company's wholly-owned and managed retail properties include grocery-anchored community and neighborhood centers and power centers, including those classified as necessity-based. InvenTrust operates through a single segment i.e. multi-tenant retail.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: